Additional degradants in the impurity profile of atropine low-dose ophthalmic solution

• Päätekijät: Ewelina Cebulska (Tekijä), Katarzyna Malik (Tekijä), Kamila Czarnecka (Tekijä), Paweł Szymański (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Polskie Towarzystwo Farmaceutyczne, 2023-10-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

WHO has identified the increase in myopia as the world's greatest threat to vision health due to its association with vision-threatening complications like myopic macular degeneration, retinal detachment, cataract and open angle glaucoma. Pharmacological treatment with atropine is assessed as o...